Established research on intranasal peptide delivery exists for oxytocin, insulin, and several neuropeptides
He views this as part of comprehensive hormone optimization for a man in his fifties who wants to maintain peak performance
Basic pharmacokinetic parameters including absorption, distribution, metabolism, and excretion characteristics in human subjects would inform rational dosing strategies and identify potential sources of pharmacokinetic variability affecting individual response
Per-IU equivalence on a U100 syringe At 2 mL reconstitution (the typical research middle ground): 1 IU on a U100 syringe corresponds to 250 micrograms of GHK-Cu, 50 micrograms of TB-500, and 50 micrograms of BPC-157
Practical Considerations for Research & Clinical Context Given your clinics focus on peptides, hormone replacement, body composition, DEXA scanning and regenerative medicine, how might FOXO4-DRI fit into the broader strategyand what to watch out for